Literature DB >> 2699167

Surgical pathology of the syndrome of primary sclerosing cholangitis.

J Ludwig1.   

Abstract

The diagnosis of primary sclerosing cholangitis (PSC) is based on the characteristic cholangiographic manifestations of the condition. Surgical biopsy specimens from extrahepatic bile ducts are not diagnostic. They should be obtained only if the presence of bile duct carcinoma must be ruled out. If liver transplantation is anticipated, even that procedure may be contraindicated. Gallbladder disease in PSC is common but again, histologic findings are not diagnostic. Intrahepatic cholangiectases in combination with bile duct obliteration are characteristic for PSC, but tissue samples with these lesions usually are unavailable during work-up of patients. Histologic changes in routine needle or wedge biopsy specimens from the liver may strongly support the diagnosis of PSC. The most important histologic abnormality is the absence of interlobular bile ducts in some portal tracts (ductopenia), which often coexists with evidence of ductal proliferation in other portal tracts. Portal edema and ductular proliferation frequently accompany these changes. Liver biopsy study in PSC is recommended not only for diagnostic purposes but also because the procedure allows staging of the liver disease and thus helps to determine the prognosis of patients, contributes to the decision-making process for liver transplantation, and facilitates therapeutic trials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2699167

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Primary sclerosing cholangitis--approach to diagnosis.

Authors:  Ian L Steele; Cynthia Levy; Keith D Lindor
Journal:  MedGenMed       Date:  2007-04-25

3.  Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.

Authors:  Toru Takahashi; Tomofumi Miura; Junichiro Nakamura; Satoshi Yamada; Tsutomu Miura; Masahiko Yanagi; Yasunobu Matsuda; Hiroyuki Usuda; Iwao Emura; Koichi Tsuneyama; Xiao-Song He; M Eric Gershwin
Journal:  Hepatology       Date:  2012-03       Impact factor: 17.425

4.  Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis.

Authors:  R Olsson; I Hägerstrand; U Broomé; A Danielsson; G Järnerot; L Lööf; H Prytz; B O Rydén; S Wallerstedt
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

Review 5.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

6.  Sclerosing cholangitis: pediatric perspective.

Authors:  Nanda Kerkar; Tamir Miloh
Journal:  Curr Gastroenterol Rep       Date:  2010-06

Review 7.  Primary sclerosing cholangitis: diagnosis, prognosis, and management.

Authors:  Siddharth Singh; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-27       Impact factor: 11.382

Review 8.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

Review 9.  Clinical features and management of primary sclerosing cholangitis.

Authors:  Marina-G Silveira; Keith-D Lindor
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 10.  [Autoimmune liver diseases].

Authors:  S Lüth; C Weiler-Normann; C Schramm; A W Lohse
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.